NanoViricides Inc. (NNVC)

[arvitar]

NEWS FLASH: No "drug" from NNVC exists.

NNVC hasn't even managed to get an approved IND application for a single preclinical candidate after 11 years and $63M.

Before a "drug" can exist, a candidate must survive the IND studies, and then Phase-I, II, III studies, and then gain market approval by the FDA.

Based on where NNVC is today, the FDA says their overall probability of success is 8%, and another 11 to 14 years away:

http://www.fdareview.org/03_drug_development.php

And that's assuming NNVC's too-good-to-be-true story is actually true, and their management spontaneously develops the knowledge and skills required to competently develop a drug.